Jove
Visualize
Contact Us

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

95
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
95
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

6
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
6
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

62
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
62
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.3K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

69
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
69
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.0K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parvovirus B19 Infection in Kidney Transplant Recipients: Clinical Spectrum, Management, and Outcomes in a Large Multicentered Indian Cohort.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Clinicopathological Features and Outcomes of Fibrillary Glomerulonephritis in an Indian Cohort: A Multicentric Study.

Kidney medicine·2025
Same author

Fever of Unknown Origin in a Renal Transplant Recipient.

Indian journal of nephrology·2025
Same author

Evolving Gender Dynamics in India's Nephrology Workforce: A Decadal Analysis (2013-2023).

Nephrology (Carlton, Vic.)·2025
Same author

Study Design of a Nationwide Network Indian Cohort of Pregnancy-Associated Acute Kidney Injury (iPRAKI NET).

Kidney international reports·2025
Same author

Post-Diarrheal Acute Kidney Injury During an Epidemic in Monsoon - A Retrospective Study from a Tertiary Care Hospital.

Indian journal of nephrology·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 5, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Hypertension- One ize does not fit all.

Mohanasundaram Subashri1, M Edwin Fernando1, K Thirumalvalavan1

  • 1Department of Nephrology, Government Stanley Medical College, Chennai, Tamil Nadu, India.

Indian Journal of Nephrology
|January 24, 2022
PubMed
Summary
This summary is machine-generated.

Congenital adrenal hyperplasia (CAH) can cause secondary hypertension. This study details a young adult with hypertension due to 11-beta hydroxylase deficiency, highlighting successful steroid treatment and new gene mutations.

Keywords:
11 β hydroxylase deficiencycongenital adrenal hyperplasiahypertensionhypokalemia

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.5K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

363

Related Experiment Videos

Last Updated: Oct 5, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.5K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

363

Area of Science:

  • Endocrinology
  • Genetics
  • Hypertension Research

Background:

  • Essential hypertension is common, but secondary causes offer treatment opportunities.
  • Congenital adrenal hyperplasia (CAH) is an inherited cause of secondary hypertension.
  • Deficient adrenal corticosteroid biosynthesis in CAH alters hormone secretion.

Observation:

  • A young adult presented with hypertension, hypokalemia, and metabolic alkalosis.
  • Diagnosis revealed non-classical 11-beta hydroxylase deficiency, a form of CAH.
  • The patient showed a dramatic response to steroid therapy.

Findings:

  • Identified a non-classical variant of 11-beta hydroxylase deficiency causing secondary hypertension.
  • Reported two novel missense mutations in the CYP11B1 gene.
  • Demonstrated the efficacy of steroid therapy in managing this CAH variant.

Implications:

  • Accurate diagnosis of secondary hypertension, like CAH, enables targeted and effective treatment.
  • Understanding CYP11B1 mutations advances knowledge of adrenal biosynthesis disorders.
  • This case underscores the importance of considering CAH in hypertensive patients with specific electrolyte imbalances.